This dependency on PD-L1 expression could result from the direct interaction between CD4+ T cells and MHC-II [87], which can either reinforce the cell-killing activity of CD8+ T cells that are already engaged by MHC-I or directly kill cancer cells [88,89]. Here, CD8A is linked to cancer.